Company Filing History:
Years Active: 2018-2025
Title: Lorna Del Pilar Nunez: Innovator in RSV Research
Introduction
Lorna Del Pilar Nunez is an accomplished inventor based in Briarcliff Manor, NY, whose work has significantly advanced the understanding of respiratory syncytial virus (RSV). With a total of four patents to her name, she stands out as a leading figure in viral protein research, specifically within the pharmaceutical sector.
Latest Patents
Among Lorna's recent innovations are her patents for RSV F protein mutants. These patents encompass the RSV F protein mutants, nucleic acids or vectors encoding an RSV F protein mutant, compositions comprising the RSV F protein mutant or nucleic acid, and their various uses. This groundbreaking work in viral protein research aims to enhance therapeutic interventions against RSV, a common and serious respiratory virus.
Career Highlights
Lorna is currently associated with Pfizer Corporation, a leading global pharmaceutical company known for its commitment to innovation in health solutions. Her expertise in virology and protein design has placed her at the forefront of research initiatives aimed at combating respiratory viruses, making her a valuable asset to her company and the scientific community.
Collaborations
Throughout her career, Lorna has worked alongside esteemed colleagues such as Ye Che and Philip R. Dormitzer. These collaborations reflect a multidisciplinary approach to research in viral immunology, significantly amplifying the scope and impact of her work.
Conclusion
Lorna Del Pilar Nunez exemplifies the role of innovation in modern science. Her contributions to RSV research not only enhance our understanding of viral proteins but also pave the way for improved therapeutic strategies. With her ongoing commitment to research and development, Lorna continues to inspire future innovations in the field of infectious diseases.